封面
市場調查報告書
商品編碼
1782432

全球戒菸和尼古丁脫癮市場研究報告-產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Smoking Cessation and Nicotine De-Addiction Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

全球戒菸和尼古丁脫癮市場規模預計將從 2024 年的 329.5 億美元成長到 2033 年的 820 億美元,在 2026 年至 2033 年的預測期內,年複合成長率(CAGR) 將達到 10.66%。

隨著公共衛生計劃的推進以及人們對吸菸危害日益成長的認知,對有效戒菸解決方案的需求不斷成長,戒菸和尼古丁戒菸市場正在經歷一場範式轉移。隨著越來越多的人尋求戒菸,尼古丁替代療法 (NRT)、處方藥和行為支持計畫的市場規模也在擴大。吸菸相關健康問題的日益普遍進一步推動了這一成長,促使各國政府和醫療保健機構投資於全面的戒菸項目,為尋求戒菸的個人提供支持和資源。

此外,數位健康技術的出現正在改變戒菸格局。行動應用程式和線上平台正在成為有價值的工具,為戒菸者提供個人化支援、追蹤和激勵。這些數位解決方案通常融入行為科學原理,為使用者提供客製化策略來管理菸癮和誘因。隨著技術的不斷發展,人工智慧和機器學習與這些平台的整合將增強其有效性,從而為使用者提供更精準的干涉和支援。

此外,電子煙和加熱菸草產品等替代尼古丁輸送系統的日益普及,正在重塑戒菸市場。儘管這些產品通常被宣傳為危害較小的替代品,但它們仍然對公共衛生構成挑戰。隨著監管機構評估這些替代品的長期影響,戒菸市場需要做出調整,提供全面的解決方案,滿足尋求戒菸的個人的多樣化需求。因此,在創新、技術和改善公共健康的共同承諾的推動下,戒菸和尼古丁脫癮市場有望顯著成長。

我們的報告經過精心設計,旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分,以確保客戶全面了解市場格局:

市場概覽:市場的詳細介紹,包括定義、分類和行業現狀概述。

市場動態:深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析:根據產品類型、應用、最終用戶和地理位置等標準,將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局:對主要市場參與者的全面評估,包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了競爭態勢以及領先公司採用的關鍵策略。

市場預測:根據歷史資料和當前市場狀況,對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示,以說明未來的市場發展軌跡。

區域分析:評估不同地理區域的市場表現,確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會:識別當前及新興市場趨勢、技術創新以及潛在投資領域。本部分將深入探討未來市場發展與成長前景。

目錄

第1章:前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第3章:戒菸與尼古丁脫癮產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分析市場吸引力
    • 按形式分析市場吸引力
    • 按配銷通路分析市場吸引力
    • 市場吸引力分析:按地區

第4章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第5章:全球戒菸與尼古丁脫癮市場分析:依類型

  • 按類型概覽
  • 按類型分析歷史和預測數據
  • 尼古丁替代療法
  • 藥物治療
  • 電子煙

第6章:全球戒菸與尼古丁脫癮市場分析:依形式

  • 按形式概覽
  • 按形式分析歷史和預測數據
  • 吸入器
  • 藥片
  • 其他

第7章:全球戒菸和尼古丁脫癮市場分析:按分銷管道

  • 按配銷通路概覽
  • 按配銷通路進行的歷史和預測資料分析
  • 醫院藥房
  • 線上
  • 藥局和零售藥房

第 8 章:全球戒菸與尼古丁脫癮市場分析:按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第9章:戒菸和尼古丁脫癮公司的競爭格局

  • 戒菸和尼古丁戒菸市場競爭
  • 合作/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第10章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Rusan Pharma Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Dr. Reddy'S Laboratories Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Imperial Brands Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Zydus Group.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • British American Tobacco Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Perrigo Company Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Johnson And Johnson Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • NJOY LLC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cipla Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GlaxoSmithKline Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中,財務細節和最新發展取決於可用性,對於私人公司,可能不予涵蓋

Product Code: VMR11218851

Global Smoking Cessation and Nicotine De-Addiction Market size is anticipated to grow from USD 32.95 Billion in 2024 to USD 82 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.66% during the forecast period of 2026 to 2033.

The smoking cessation and nicotine de-addiction market is witnessing a paradigm shift as public health initiatives and growing awareness of the dangers of smoking drive demand for effective cessation solutions. With an increasing number of individuals seeking to quit smoking, the market for nicotine replacement therapies (NRTs), prescription medications, and behavioral support programs is expanding. This growth is further fueled by the rising prevalence of smoking-related health issues, prompting governments and healthcare organizations to invest in comprehensive smoking cessation programs that provide support and resources for individuals looking to quit.

Moreover, the advent of digital health technologies is transforming the smoking cessation landscape. Mobile applications and online platforms are emerging as valuable tools that offer personalized support, tracking, and motivation for individuals on their journey to quit smoking. These digital solutions often incorporate behavioral science principles, providing users with tailored strategies to manage cravings and triggers. As technology continues to evolve, the integration of artificial intelligence and machine learning into these platforms will enhance their effectiveness, enabling more precise interventions and support for users.

Additionally, the increasing popularity of alternative nicotine delivery systems, such as e-cigarettes and heated tobacco products, is reshaping the smoking cessation market. While these products are often marketed as less harmful alternatives, they still pose challenges for public health. As regulatory bodies assess the long-term effects of these alternatives, the smoking cessation market will need to adapt, offering comprehensive solutions that address the diverse needs of individuals seeking to quit. The smoking cessation and nicotine de-addiction market is thus positioned for significant growth, driven by innovation, technology, and a collective commitment to improving public health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Nicotine Replacement Therapy
  • Drug Therapy
  • E-cigarettes

By Form

  • Gum
  • Inhaler
  • Tablet
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Online
  • Drug Stores and Retail Pharmacies
  • COMPANIES PROFILED
  • Rusan Pharma Ltd
  • Dr. Reddy's Laboratories Ltd
  • Imperial Brands Plc
  • Zydus Group.
  • British American Tobacco Plc
  • Perrigo Company Plc
  • Johnson and Johnson Inc
  • NJOY LLC
  • Cipla Ltd
  • GlaxoSmithKline Plc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Form
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Nicotine Replacement Therapy Historic and Forecast Sales By Regions
  • 5.4. Drug Therapy Historic and Forecast Sales By Regions
  • 5.5. E-cigarettes Historic and Forecast Sales By Regions

6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY FORM

  • 6.1. Overview By Form
  • 6.2. Historical and Forecast Data Analysis By Form
  • 6.3. Gum Historic and Forecast Sales By Regions
  • 6.4. Inhaler Historic and Forecast Sales By Regions
  • 6.5. Tablet Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Online Historic and Forecast Sales By Regions
  • 7.5. Drug Stores and Retail Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SMOKING CESSATION AND NICOTINE DE-ADDICTION COMPANIES

  • 9.1. Smoking Cessation and Nicotine De-Addiction Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Rusan Pharma Ltd
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Dr. Reddy'S Laboratories Ltd
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Imperial Brands Plc
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Zydus Group.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. British American Tobacco Plc
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Perrigo Company Plc
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Johnson And Johnson Inc
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. NJOY LLC
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Cipla Ltd
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. GlaxoSmithKline Plc
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Nicotine Replacement Therapy Market Sales By Geography (USD MN)
  • Drug Therapy Market Sales By Geography (USD MN)
  • E-cigarettes Market Sales By Geography (USD MN)
  • Analysis By Form (USD MN)
  • Gum Market Sales By Geography (USD MN)
  • Inhaler Market Sales By Geography (USD MN)
  • Tablet Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Online Market Sales By Geography (USD MN)
  • Drug Stores and Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Smoking Cessation and Nicotine De-Addiction Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Smoking Cessation and Nicotine De-Addiction Report
  • Market Research Process
  • Market Research Methodology
  • Global Smoking Cessation and Nicotine De-Addiction Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Form
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Nicotine Replacement Therapy Market Sales By Geography (USD MN)
  • Drug Therapy Market Sales By Geography (USD MN)
  • E-cigarettes Market Sales By Geography (USD MN)
  • Global Market Analysis By Form (USD MN)
  • Gum Market Sales By Geography (USD MN)
  • Inhaler Market Sales By Geography (USD MN)
  • Tablet Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Online Market Sales By Geography (USD MN)
  • Drug Stores and Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.